Azenta, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Martin D. Madaus
- Full Time Employees
- 3,000
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- 200 Summit Drive Burlington MA United States 01803
- IPO Date
- Feb 2, 1995
- CIK
- 0000933974
- Website
- azenta.com
- Similar Companies
- Business
- Azenta, Inc. Azenta, Inc. (Nasdaq: AZTA) provides life sciences sample exploration and management solutions to pharmaceutical, biotechnology, academic, and healthcare institutions worldwide. The company offers consumables and instruments including 2D sample storage tubes and bench-top equipment from brands such as FluidX, Ziath, and 4titude; automated stores and cryogenics systems; sample storage and repository services through BioStorage Technologies; GENEWIZ multiomics and synthesis solutions encompassing next-generation sequencing, genomics, and transgene expression cassettes; sample management LIMS software like FreezerPro and Limfinity; cold chain solutions from B Medical Systems including temperature-controlled storage and transportation; and biological sample preparation from Matrical Bioscience. Azenta operates globally across North America, Europe, and Asia from its headquarters in Burlington, Massachusetts, where it was rebranded from Brooks Automation in December 2021 following a corporate restructuring that divested its semiconductor solutions group. Recent developments include a May 2025 strategic partnership with Form Bio to integrate GENEWIZ sequencing with AI-driven AAV gene therapy analysis for improved vector safety and development speed; and a November 2025 collaboration with the PRECEDE Foundation to provide biorepository storage and logistics for pancreatic cancer early detection research.
Company News
Head to Head Comparison: Champions Oncology (NASDAQ:CSBR) versus Azenta (NASDAQ:AZTA)
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
Azenta: A Sample Custody Annuity Priced Like A Broken Equipment Vendor
ROSEN, LEADING INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
ROSEN, HIGHLY REGARDED TRIAL ATTORNEYS, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
ROSEN, A LEADING LAW FIRM, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Azenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis Capabilities
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
Azenta Announces Fiscal 2026 Fourth Quarter and Full Year Conference Call and Webcast
ROSEN, LEADING INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
ROSEN, LEADING INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
ROSEN, LEADING INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA